Why the study?
Does recombinant TMD123 reduce arterial dilatation and neointima formation in a mouse carotid ligation model?
Does recombinant TMD123 reduce arterial dilatation and neointima formation in a mouse carotid ligation model?
Early treatment with recombinant thrombomodulin reduces vascular remodeling and neointima formation in a mouse model of carotid ligation.
No takes yet. Share an insight, caveat, or question.
Attenuates remodeling in mouse carotid ligation; leaves open translation to human restenosis prevention.
Li et al. (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: